Skip to content

Study · Not a test of the peptide alone · 2019

2 results

A Case Report on the Use of Pharmacological Intervention in the Treatment of Diffuse Axonal Injury From Road Traffic Accidents.

Previgliano I, Soto MA

Journal of medicine and life1 Oct 2019

PMID32025270 (opens in a new tab)PMCIDPMC6993291 (opens in a new tab)DOI10.25122/jml-2019-1012 (opens in a new tab)PepBankPUB-32025270
Download PDFPubMedAsk about this study
Jump to 2 results

Summary

We report a case of traumatic brain injury treated with Cerebrolysin, a neurorecovery stimulating agent. Our therapeutic approach was based on the pathophysiology of traumatic brain injury and, in particular, of diffuse axonal injury. The patient registered marked improvement in mood and cognitive performance, indicating the effectiveness of multimodal and multidisciplinary interventions after traumatic brain injury.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In a traumatic brain injury case, multimodal interventions including Cerebrolysin were followed by marked mood improvement.

    In plain wordsIn a brain injury case, multimodal interventions including Cerebrolysin were followed by marked mood improvement.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseMood
    Study

    n = 1

    Outcome group
    Anxiety and mood · Mental health and mood

    Source sentences

    Summary
    The patient registered marked improvement in mood and cognitive performance, indicating the effectiveness of multimodal and multidisciplinary interventions after traumatic brain injury.
    2 context sentences
    Summary · context
    We report a case of traumatic brain injury treated with Cerebrolysin, a neurorecovery stimulating agent.
    Summary · context
    Our therapeutic approach was based on the pathophysiology of traumatic brain injury and, in particular, of diffuse axonal injury.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 02HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In a traumatic brain injury case, multimodal interventions including Cerebrolysin were followed by marked cognitive improvement.

    In plain wordsIn a brain injury case, multimodal interventions including Cerebrolysin were followed by marked cognitive improvement.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseCognitive performance
    Study

    n = 1

    Outcome group
    Cognition and memory · Nervous system and cognition

    Source sentences

    Summary
    The patient registered marked improvement in mood and cognitive performance, indicating the effectiveness of multimodal and multidisciplinary interventions after traumatic brain injury.
    2 context sentences
    Summary · context
    We report a case of traumatic brain injury treated with Cerebrolysin, a neurorecovery stimulating agent.
    Summary · context
    Our therapeutic approach was based on the pathophysiology of traumatic brain injury and, in particular, of diffuse axonal injury.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.